AMLX
Price
$18.25
Change
-$0.06 (-0.33%)
Updated
Oct 2, 1:18 PM EST
38 days until earnings call
REGN
Price
$813.57
Change
-$9.39 (-1.14%)
Updated
Oct 2, 11:03 AM EST
36 days until earnings call

AMLX vs REGN ᐉ Comparison: Which is Better to Invest?

Header iconAMLX vs REGN Comparison
Open Charts AMLX vs REGNBanner chart's image
Amylyx Pharmaceuticals
Price$18.25
Change-$0.06 (-0.33%)
Volume$100
CapitalizationN/A
Regeneron Pharmaceuticals
Price$813.57
Change-$9.39 (-1.14%)
Volume$1.02K
CapitalizationN/A
View a ticker or compare two or three
AMLX vs REGN Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
AMLX vs. REGN commentary
Oct 02, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and REGN is a StrongBuy.

COMPARISON
Comparison
Oct 02, 2023
Stock price -- (AMLX: $18.31 vs. REGN: $823.27)
Brand notoriety: AMLX: Not notable vs. REGN: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 72% vs. REGN: 63%
Market capitalization -- AMLX: $1.25B vs. REGN: $90.6B
AMLX [@Biotechnology] is valued at $1.25B. REGN’s [@Biotechnology] market capitalization is $90.6B. The market cap for tickers in the [@Biotechnology] industry ranges from $410.54B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileREGN’s FA Score has 2 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • REGN’s FA Score: 2 green, 3 red.
According to our system of comparison, REGN is a better buy in the long-term than AMLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish while REGN’s TA Score has 3 bullish TA indicator(s).

  • AMLX’s TA Score: 4 bullish, 4 bearish.
  • REGN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AMLX is a better buy in the short-term than REGN.

Price Growth

AMLX (@Biotechnology) experienced а -0.92% price change this week, while REGN (@Biotechnology) price change was -0.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.39%. For the same industry, the average monthly price growth was +18.43%, and the average quarterly price growth was +21.40%.

Reported Earning Dates

AMLX is expected to report earnings on Nov 09, 2023.

REGN is expected to report earnings on Nov 07, 2023.

Industries' Descriptions

@Biotechnology (+0.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for AMLX with price predictions.
OPEN
A.I.dvisor published
a Summary for REGN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
REGN($90.6B) has a higher market cap than AMLX($1.25B). REGN YTD gains are higher at: 14.107 vs. AMLX (-50.447). REGN has higher annual earnings (EBITDA): 5.24B vs. AMLX (-80.29M). REGN has more cash in the bank: 8.93B vs. AMLX (357M). AMLX has less debt than REGN: AMLX (5.29M) vs REGN (2.7B). REGN has higher revenues than AMLX: REGN (12.7B) vs AMLX (192M).
AMLXREGNAMLX / REGN
Capitalization1.25B90.6B1%
EBITDA-80.29M5.24B-2%
Gain YTD-50.44714.107-358%
P/E RatioN/A22.08-
Revenue192M12.7B2%
Total Cash357M8.93B4%
Total Debt5.29M2.7B0%
FUNDAMENTALS RATINGS
REGN: Fundamental Ratings
REGN
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
7
SMR RATING
1..100
49
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
21
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXREGN
RSI
ODDS (%)
Bullish Trend 4 days ago
64%
Bearish Trend 4 days ago
51%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
58%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
55%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
53%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
57%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
62%
Advances
ODDS (%)
Bullish Trend 7 days ago
74%
Bullish Trend 5 days ago
64%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 12 days ago
54%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
67%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
71%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMMTX14.480.07
+0.49%
Russell Inv Emerging Markets M
JANRX16.52N/A
N/A
Janus Henderson Global Select D
ANVIX25.09N/A
N/A
Virtus NFJ Large-Cap Value Fund Inst
FOCKX16.47-0.01
-0.06%
Fidelity® OTC K
AQLGX14.27-0.03
-0.21%
Alta Quality Growth Institutional

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been loosely correlated with SNDX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AMLX jumps, then SNDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
-1.03%
SNDX - AMLX
45%
Loosely correlated
-7.10%
AGEN - AMLX
41%
Loosely correlated
N/A
ALNY - AMLX
39%
Loosely correlated
+1.76%
BEAM - AMLX
39%
Loosely correlated
+0.12%
KRTX - AMLX
39%
Loosely correlated
-0.62%
More

REGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, REGN has been loosely correlated with VRTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if REGN jumps, then VRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REGN
1D Price
Change %
REGN100%
-1.35%
VRTX - REGN
44%
Loosely correlated
-1.35%
INCY - REGN
38%
Loosely correlated
-1.42%
NKTX - REGN
38%
Loosely correlated
-7.33%
GBIO - REGN
38%
Loosely correlated
+0.53%
SRNEQ - REGN
36%
Loosely correlated
-6.19%
More